DK1653963T3 - Nasal farmaceutisk sammensætning piribedil - Google Patents

Nasal farmaceutisk sammensætning piribedil

Info

Publication number: DK1653963T3
Authority: DK; Denmark
Prior art keywords: piribedil; pharmaceutical composition; nasal pharmaceutical; nasal; composition
Prior art date: 2003-07-17

Application number

DK04767691T

Other languages

English (en)

Inventor

Herve Rolland

Patrick Wuthrich

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-17

Filing date

2004-07-16

Publication date

2007-04-10

2004-07-16 Application filed by Servier Lab filed Critical Servier Lab

2007-04-10 Application granted granted Critical

2007-04-10 Publication of DK1653963T3 publication Critical patent/DK1653963T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK04767691T 2003-07-17 2004-07-16 Nasal farmaceutisk sammensætning piribedil DK1653963T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0308712A FR2857594B1 (fr)	2003-07-17	2003-07-17	Composition pharmaceutique pour l'administration par voie nasale de piribedil
PCT/FR2004/001867 WO2005009442A1 (fr)	2003-07-17	2004-07-16	Composition pharmaceutique pour l’administration par voie nasale de piribedil

Publications (1)

Publication Number	Publication Date
DK1653963T3 true DK1653963T3 (da)	2007-04-10

Family

ID=33548200

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04767691T DK1653963T3 (da)	2003-07-17	2004-07-16	Nasal farmaceutisk sammensætning piribedil

Country Status (29)

Country	Link
US (1)	US20060204449A1 (da)
EP (1)	EP1653963B1 (da)
JP (1)	JP2007516947A (da)
KR (1)	KR100807480B1 (da)
CN (1)	CN100540004C (da)
AR (1)	AR046808A1 (da)
AT (1)	ATE349213T1 (da)
AU (1)	AU2004258714A1 (da)
BR (1)	BRPI0412681A (da)
CA (1)	CA2532631C (da)
CY (1)	CY1106013T1 (da)
DE (1)	DE602004003955T2 (da)
DK (1)	DK1653963T3 (da)
EA (1)	EA011041B1 (da)
ES (1)	ES2279435T3 (da)
FR (1)	FR2857594B1 (da)
GE (1)	GEP20074259B (da)
HR (1)	HRP20070081T5 (da)
MA (1)	MA27864A1 (da)
MX (1)	MXPA06000641A (da)
MY (1)	MY137747A (da)
NO (1)	NO332776B1 (da)
NZ (1)	NZ544460A (da)
PL (1)	PL1653963T3 (da)
PT (1)	PT1653963E (da)
SI (1)	SI1653963T1 (da)
UA (1)	UA85193C2 (da)
WO (1)	WO2005009442A1 (da)
ZA (1)	ZA200600240B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO2303330T3 (da) *	2008-06-06	2018-04-14
CN105163729A (zh) *	2013-03-13	2015-12-16	N到B有限公司	用于治疗与帕金森氏病相关的运动和抑郁症状的方法、组合物和装置
IT201800005117A1 (it)	2018-05-07	2019-11-07		Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE1007402A5 (nl) *	1993-03-26	1995-06-06	Adir	Nasale farmaceutische preparaten met progestagene stof.
ATE241984T1 (de) *	1993-03-26	2003-06-15	Franciscus Wilhelmus He Merkus	Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
FR2710268B1 (fr) *	1993-09-22	1995-10-20	Adir	Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2710265B1 (fr) *	1993-09-22	1995-10-20	Adir	Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2742989B1 (fr) *	1995-12-29	1998-01-23	Adir	Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
JP2001518923A (ja) *	1997-03-26	2001-10-16	ダブリュエイチエムマーカス，フランシスカス	鼻腔用メラトニン組成物
EP0900567A3 (en) *	1997-09-05	2001-05-02	Pfizer Products Inc.	Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
US20020002175A1 (en) *	2000-09-19	2002-01-03	Charanjit Behl	Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) *	2001-06-25	2004-02-12	Nastech Pharmaceutical Company Inc	Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) *	2001-07-19	2003-09-19	Servier Lab	Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

2003
- 2003-07-17 FR FR0308712A patent/FR2857594B1/fr not_active Expired - Fee Related
2004
- 2004-07-15 MY MYPI20042838A patent/MY137747A/en unknown
- 2004-07-15 AR ARP040102489A patent/AR046808A1/es unknown
- 2004-07-16 AT AT04767691T patent/ATE349213T1/de active
- 2004-07-16 MX MXPA06000641A patent/MXPA06000641A/es active IP Right Grant
- 2004-07-16 GE GEAP20049239A patent/GEP20074259B/en unknown
- 2004-07-16 HR HR20070081T patent/HRP20070081T5/xx unknown
- 2004-07-16 ES ES04767691T patent/ES2279435T3/es not_active Expired - Lifetime
- 2004-07-16 AU AU2004258714A patent/AU2004258714A1/en not_active Abandoned
- 2004-07-16 UA UAA200601630A patent/UA85193C2/ru unknown
- 2004-07-16 BR BRPI0412681-5A patent/BRPI0412681A/pt not_active IP Right Cessation
- 2004-07-16 ZA ZA200600240A patent/ZA200600240B/en unknown
- 2004-07-16 PL PL04767691T patent/PL1653963T3/pl unknown
- 2004-07-16 DK DK04767691T patent/DK1653963T3/da active
- 2004-07-16 CN CNB2004800197495A patent/CN100540004C/zh not_active Expired - Fee Related
- 2004-07-16 WO PCT/FR2004/001867 patent/WO2005009442A1/fr not_active Ceased
- 2004-07-16 PT PT04767691T patent/PT1653963E/pt unknown
- 2004-07-16 DE DE602004003955T patent/DE602004003955T2/de not_active Expired - Lifetime
- 2004-07-16 JP JP2006519966A patent/JP2007516947A/ja active Pending
- 2004-07-16 KR KR1020067001141A patent/KR100807480B1/ko not_active Expired - Fee Related
- 2004-07-16 NZ NZ544460A patent/NZ544460A/en not_active IP Right Cessation
- 2004-07-16 SI SI200430163T patent/SI1653963T1/sl unknown
- 2004-07-16 US US10/564,139 patent/US20060204449A1/en not_active Abandoned
- 2004-07-16 CA CA2532631A patent/CA2532631C/fr not_active Expired - Fee Related
- 2004-07-16 EP EP04767691A patent/EP1653963B1/fr not_active Expired - Lifetime
- 2004-07-16 EA EA200600172A patent/EA011041B1/ru not_active IP Right Cessation
2005
- 2005-12-27 MA MA28688A patent/MA27864A1/fr unknown
2006
- 2006-02-16 NO NO20060743A patent/NO332776B1/no not_active IP Right Cessation
2007
- 2007-02-13 CY CY20071100190T patent/CY1106013T1/el unknown

Also Published As

Publication number	Publication date
BRPI0412681A (pt)	2006-10-03
US20060204449A1 (en)	2006-09-14
NO20060743L (no)	2006-02-16
EA200600172A1 (ru)	2006-06-30
PL1653963T3 (pl)	2007-02-28
KR20060031689A (ko)	2006-04-12
SI1653963T1 (sl)	2007-04-30
WO2005009442A1 (fr)	2005-02-03
DE602004003955D1 (de)	2007-02-08
ES2279435T3 (es)	2007-08-16
EP1653963B1 (fr)	2006-12-27
FR2857594B1 (fr)	2005-09-16
HRP20070081T3 (hr)	2007-04-30
NO332776B1 (no)	2013-01-14
EA011041B1 (ru)	2008-12-30
JP2007516947A (ja)	2007-06-28
FR2857594A1 (fr)	2005-01-21
HRP20070081T5 (hr)	2007-08-31
MA27864A1 (fr)	2006-04-03
AR046808A1 (es)	2005-12-28
CN100540004C (zh)	2009-09-16
CY1106013T1 (el)	2011-04-06
ZA200600240B (en)	2007-03-28
KR100807480B1 (ko)	2008-02-25
CA2532631A1 (fr)	2005-02-03
EP1653963A1 (fr)	2006-05-10
MXPA06000641A (es)	2006-03-30
MY137747A (en)	2009-03-31
AU2004258714A1 (en)	2005-02-03
CA2532631C (fr)	2011-01-04
NZ544460A (en)	2008-04-30
PT1653963E (pt)	2007-02-28
UA85193C2 (ru)	2009-01-12
ATE349213T1 (de)	2007-01-15
GEP20074259B (en)	2007-12-10
DE602004003955T2 (de)	2007-12-06
CN1819828A (zh)	2006-08-16
HK1094153A1 (zh)	2007-03-23

Publication	Publication Date	Title
ATE380544T1 (de)	2007-12-15	Umhüllte feste darreichungsform
DK1545662T3 (da)	2020-05-25	Lægemiddelindgivelsessystem
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
DE502004003234D1 (de)	2007-04-26	Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de)	2007-08-09	Gegen missbrauch gesicherte darreichungsform
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
DE602004017700D1 (de)	2008-12-24	Transmukosen verabreichung
CY2017048I1 (el)	2018-09-05	Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
CY2018005I2 (el)	2018-06-27	Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
PT1467724E (pt)	2006-08-31	Composicao farmaceutica orodispersavel de agomelatina
IS8352A (is)	2006-03-14	Ný rópínírólsamsetning
DE60335075D1 (de)	2011-01-05	Flüssigkeitszerstäuber
DE602004022810D1 (de)	2009-10-08	Mehrdosis-inhalator
DE112004001618D2 (de)	2006-05-11	Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
DK1653963T3 (da)	2007-04-10	Nasal farmaceutisk sammensætning piribedil
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
NO20034952D0 (no)	2003-11-06	Farmasöytiske forbindelser
DK1675637T3 (da)	2017-11-13	Inhalator
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
NO20044164L (no)	2004-09-30	Farmasoytiske sammensetninger
PT1467737E (pt)	2006-08-31	Composicao farmaceutica orodispersivel de piribedil
DE112004001429D2 (de)	2006-04-13	Pharmazeutischer Wirkstoff
DE502004004196D1 (de)	2007-08-09	Ultraschall-stehwellen-zerstäuberanordnung
FI20030224A0 (fi)	2003-02-13	Uudet farmaseuttiset käytöt